KMT2A and acute myeloid leukemia: DS-1594a·HCl and DS-1594a·succinate displayed selective growth inhibition against AML and ALL cells with MLL1-r or NPM1c and demonstrated robust and durable antitumor activity in AML/ALL mouse models.